BE765809A - Anti-alcoholic compsns contng calcium 5-buty - Google Patents
Anti-alcoholic compsns contng calcium 5-butyInfo
- Publication number
- BE765809A BE765809A BE765809A BE765809A BE765809A BE 765809 A BE765809 A BE 765809A BE 765809 A BE765809 A BE 765809A BE 765809 A BE765809 A BE 765809A BE 765809 A BE765809 A BE 765809A
- Authority
- BE
- Belgium
- Prior art keywords
- calcium
- alcoholic
- contng
- compsns
- buty
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
Anti-alcoholic compsn. comprise a carrier and, as active ingredient, calcium 5-butylpicolinate (I) or calcium 5-pentyl-picolinate (II), in an amount of 50-200 mg per unit does. (I) and (II) inhibit dopamine-beta-hydroxylase, and are pref. administered orally at the rate of 200-800 mg/day in three or four unit doses. They are non-irritant to the stomach and non-toxic to patients suffering from hypertension.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
BE765809A BE765809A (en) | 1971-04-15 | 1971-04-15 | Anti-alcoholic compsns contng calcium 5-buty |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
BE765809A BE765809A (en) | 1971-04-15 | 1971-04-15 | Anti-alcoholic compsns contng calcium 5-buty |
Publications (1)
Publication Number | Publication Date |
---|---|
BE765809A true BE765809A (en) | 1971-08-30 |
Family
ID=3857979
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
BE765809A BE765809A (en) | 1971-04-15 | 1971-04-15 | Anti-alcoholic compsns contng calcium 5-buty |
Country Status (1)
Country | Link |
---|---|
BE (1) | BE765809A (en) |
-
1971
- 1971-04-15 BE BE765809A patent/BE765809A/en not_active IP Right Cessation
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ES8307095A1 (en) | Pharmaceutical Formulation. | |
IE37378B1 (en) | Taste-improving formulations of oral penicillins | |
IE42950L (en) | X-ray contrast preparations | |
KR890003391A (en) | Calcium supplements | |
NO137899C (en) | ANALOGICAL PROCEDURE FOR THE PREPARATION OF THERAPEUTIC ACTIVE N (1H-TETRAZOL-5-YL) -KINAL DAMIDES | |
GB1487334A (en) | Pharmaceutical preparations comprising lisuride and/or physiologically tolerable salts thereof | |
NL7104752A (en) | Anti-alcoholic compsns contng calcium 5-buty | |
FR2132601A1 (en) | Anti-alcoholic compsns contng calcium 5-buty | |
BE765809A (en) | Anti-alcoholic compsns contng calcium 5-buty | |
GB1118606A (en) | Compositions for the treatment of haemorrhoids | |
FR2081364A1 (en) | Compsn for oral calcitherapy | |
EP0093497A3 (en) | Anthelmintic treatment | |
ES8502332A1 (en) | Galenic forms of sulpiride for oral administration. | |
US4216207A (en) | Method and composition for treatment of gastro-duodenal ulcers | |
ES436179A1 (en) | Physiological substances for intensifying the pharmacological effect of drugs | |
IE36780L (en) | Pharmaceutical preparations | |
GB1437138A (en) | Method of increasing sexual potency | |
REIMANN et al. | Chloramphenicol in Paratyphoid A: Observations with a Note on the Clinical Aspects of the Disease | |
GB1424611A (en) | Pharmaceutical compositions | |
DAVIS | Thiabendazole in Pinworm Infestations: II. Comparison of Single and Intermittent Therapy, Long-Term Follow-Up, and Evaluation of New Dosage Form | |
FR2085730A1 (en) | Salicylamide salts for oral administration | |
FR2059478A1 (en) | Anticarcinogenic compns contng vitamin a - acids | |
FR2059480A1 (en) | Anticarcinogenic compns contng vitamin a - acids | |
FR2105044A1 (en) | Ortho-amino benzo phenone or its oxime - as anti-rheumatic agent | |
GB1422745A (en) | Pharmaceutical compositions containing 4-hydroxy- 1,23-benzotriazine and methods of using same |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
RE | Patent lapsed |
Owner name: ZAIDAN HOJIN BISEIBUTSU KAGAKU KENKYU KAI Effective date: 19870430 |